| Serial Number | 88369612 |
| Word Mark | KALEIDO |
| Filing Date | Wednesday, April 3, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 23, 2021 |
| Registration Number | 6301922 |
| Registration Date | Tuesday, March 23, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 12, 2019 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the word "KALEIDO" to the right of the stylized representation of a round kaleidoscope image. |
| Goods and Services | Preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 22, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, February 19, 2019 |
| First Use In Commerce Date | Wednesday, July 8, 2020 |
| Party Name | Kaleido Biosciences, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Party Name | Kaleido Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Party Name | Kaleido Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Event Date | Event Description |
| Tuesday, March 23, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 16, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, February 15, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, February 4, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, January 7, 2021 | USE AMENDMENT FILED |
| Wednesday, January 27, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, January 7, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, July 9, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 7, 2020 | EXTENSION 1 GRANTED |
| Tuesday, July 7, 2020 | EXTENSION 1 FILED |
| Tuesday, July 7, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, January 7, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 12, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 12, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 23, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, October 10, 2019 | ASSIGNED TO LIE |
| Saturday, October 5, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, October 4, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 2, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 2, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 2, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, June 14, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 14, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, June 14, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, June 13, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, April 23, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, April 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, April 6, 2019 | NEW APPLICATION ENTERED IN TRAM |